Syndax Pharmaceuticals IncSNDX

時価総額

$13.1億

PER

	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Cash and cash equivalents	24	35	34	25	115	222	74
Restricted cash	-	-	-	0	0	0	-
Short-term investments	81	95	47	35	178	218	401
Short-term deposits	-	-	-	-	5	7	9
Collaboration receivable	-	-	-	-	-	-	3
Prepaid expenses and other current assets	3	3	2	3	6	8	2
Total current assets	109	133	83	62	299	448	490
Long-Term Investments	-	3	-	-	-	-	5
Property and equipment, net	0	0	0	0	0	0	0
Right-of-use asset	-	-	-	1	0	1	1
Restricted cash	-	-	-	-	-	-	0
Other assets	0	0	0	0	1	-	1
Total assets	109	137	84	64	301	450	497
Accounts payable	2	2	1	6	4	6	4
Accrued Liabilities and Other Liabilities	7	12	13	10	11	14	24
Operating Lease, Liability, Current	-	-	-	0	0	0	0
Current Portion Of Capital Lease	-	-	-	-	-	-	0
Derivative liability	-	-	-	-	-	0	-
Total current liabilities	10	16	16	18	19	21	29
Operating Lease, Liability, Noncurrent	-	-	-	0	0	1	1
Capital Lease Less Current Portion	-	-	-	-	-	-	0
Loans Payable, Noncurrent	-	-	-	-	18	20	-
Total long-term liabilities	15	17	15	14	30	21	1
Total liabilities	25	33	31	32	48	41	30
Preferred Stock, Value, Issued	-	-	-	-	-	-	-
Common Stock, Value, Issued	0	0	0	0	0	0	0
Additional paid-in capital	389	471	492	527	821	952	1,161
Accumulated other comprehensive (loss) income	0	-0	-0	-	-0	0	-1
Accumulated deficit	-305	-366	-439	-495	-569	-544	-693
Total stockholders' equity	84	104	53	32	252	408	467
Total liabilities and stockholders' equity	109	137	84	64	301	450	497